Tenax Therapeutics, Inc.

Q1 2024 13F Holders

Symbol
TENX
CUSIP
88032L605
Type
Equity
Class
COM NEW
Num filings
12
Total reported value, excl. options
$32.7 k
Manager Report Date Value ($000) Shares Option Type